Charcot-Marie-Tooth Disease Type 1A: Experimental Three Part Therapy Shows Potential
source: pixabay.com

Charcot-Marie-Tooth Disease Type 1A: Experimental Three Part Therapy Shows Potential

According to a story from Charcot-Marie-Tooth News, a recent study suggests that the three components of the investigational therapy PXT3003 work in synergy to improve the condition of patients with…

Continue Reading Charcot-Marie-Tooth Disease Type 1A: Experimental Three Part Therapy Shows Potential
Charcot-Marie-Tooth Disease: CMT Australia Gets $10,000 Grant Towards Youth Outreach
source: pixabay.com

Charcot-Marie-Tooth Disease: CMT Australia Gets $10,000 Grant Towards Youth Outreach

According to a story from Charcot-Marie-Tooth News, the nonprofit organization CMT Australia, which focuses on serving the Charcot-Marie-Tooth disease patient community in Australia, has recently acquired a grant to the…

Continue Reading Charcot-Marie-Tooth Disease: CMT Australia Gets $10,000 Grant Towards Youth Outreach
ICYMI: Better Research Means Better Outcomes for Charcot-Marie-Tooth Disease Patients
source: pixabay.com

ICYMI: Better Research Means Better Outcomes for Charcot-Marie-Tooth Disease Patients

Researchers have been trying for years to better understand the mutations which cause the rare disorder called Charcot-Marie-Tooth disease (CMT). Tremendous progress has been made. But now that we know…

Continue Reading ICYMI: Better Research Means Better Outcomes for Charcot-Marie-Tooth Disease Patients
New Study Evaluates Peripheral Neuropathy Associated with Chemotherapy in Charcot-Marie-Tooth Disease Gene Variants
source: pixabay.com

New Study Evaluates Peripheral Neuropathy Associated with Chemotherapy in Charcot-Marie-Tooth Disease Gene Variants

Chemotherapy-induced peripheral neuropathy, or CIPN, is a common side effect of chemotherapy. A recent study aimed to uncover whether or not oxaliplatin chemotherapy increased risk of CIPN for those with…

Continue Reading New Study Evaluates Peripheral Neuropathy Associated with Chemotherapy in Charcot-Marie-Tooth Disease Gene Variants
New Study Finds Potential RNA Treatment for Charcot-Marie-Tooth Disease Type 1 A
source: pixabay.com

New Study Finds Potential RNA Treatment for Charcot-Marie-Tooth Disease Type 1 A

CMT1A Charcot-Marie-Tooth disease (CMT) has a few different subtypes. 60% of all patients diagnosed with type 1 of the rare disease have CMT1A. This subtype means patients have an duplicate copy…

Continue Reading New Study Finds Potential RNA Treatment for Charcot-Marie-Tooth Disease Type 1 A

New Marker Found to Track Disease Progression in Charcot-Marie-Tooth Disease Type 1a

A study conducted by researchers from Aix-Marseille University in France has revealed a new way to track disease progression of Charcot-Marie-Tooth disease type 1a (CMT1a)- changes to the nerves within the thigh.…

Continue Reading New Marker Found to Track Disease Progression in Charcot-Marie-Tooth Disease Type 1a
SEPT9 Gene Variant Plays Role in Development of Charcot-Marie-Tooth Disease
source: pixabay.com

SEPT9 Gene Variant Plays Role in Development of Charcot-Marie-Tooth Disease

  According to Charcot-Marie-Tooth News, a recent case study found that a variation of the SEPT9 gene could contribute to the development of Charcot-Marie-Tooth disease. Read the full findings in BMC Medical Genetics. Charcot-Marie-Tooth…

Continue Reading SEPT9 Gene Variant Plays Role in Development of Charcot-Marie-Tooth Disease

This Journal Highlights Current Research on Neuromuscular Diseases (NMD)

In a Special Issue of the journal Disease Models and Mechanisms Highlights, James J. Dowling et al describes pediatric neuromuscular diseases as mostly genetic and affecting areas of the peripheral…

Continue Reading This Journal Highlights Current Research on Neuromuscular Diseases (NMD)
The Institute for Gene Therapies is Working to Improve Policy and Access for Charcot-Marie-Tooth Disease and Others
source: pixabay.com

The Institute for Gene Therapies is Working to Improve Policy and Access for Charcot-Marie-Tooth Disease and Others

The Institute for Gene Therapies (IGT) is a new development, aimed at improving the speed of development and accessibility of gene therapies. Gene Therapy Many rare diseases are caused by…

Continue Reading The Institute for Gene Therapies is Working to Improve Policy and Access for Charcot-Marie-Tooth Disease and Others
The Muscular Dystrophy Association Steps up for Rare Neuromuscular Diseases
source: pixabay.com

The Muscular Dystrophy Association Steps up for Rare Neuromuscular Diseases

According to a story from Charcot-Marie-Tooth News, the Muscular Dystrophy Association (MDA) may at first seem like a group that is solely focused on helping muscular dystrophy patients, but its…

Continue Reading The Muscular Dystrophy Association Steps up for Rare Neuromuscular Diseases
An Investigative Therapy for Charcot-Marie-Tooth Disease Type 1A has Shown Lasting Results
source: pixabay.com

An Investigative Therapy for Charcot-Marie-Tooth Disease Type 1A has Shown Lasting Results

Phase 3 Trial A Phase 3 trial run by Pharnext examining the safety and the efficacy of an investigative therapy called PXT3003 began in December of 2015. It enrolled 323…

Continue Reading An Investigative Therapy for Charcot-Marie-Tooth Disease Type 1A has Shown Lasting Results

Experimental Treatment for Facioscapulohumeral Muscular Dystrophy has Disappointing Results but May Still Benefit Charcot-Marie-Tooth Disease

The Bad News Unfortunately, it has recently been announced that an experimental treatment for facioscapulohumeral muscular dystrophy (FSHD) will not be continuing on in clinical trials. This is because the…

Continue Reading Experimental Treatment for Facioscapulohumeral Muscular Dystrophy has Disappointing Results but May Still Benefit Charcot-Marie-Tooth Disease

This Company Just Announced Plans to Develop a Gene Therapy for Type 2A Charcot-Marie-Tooth Disease

According to a story from BioSpace, the genetic medicines company Passage Bio recently announced plans for its sixth program for gene therapy development. The company plans to work with the…

Continue Reading This Company Just Announced Plans to Develop a Gene Therapy for Type 2A Charcot-Marie-Tooth Disease
Study Focuses on Muscle Weakness in Patients with Charcot-Marie-Tooth Disease Type 1A
Pezibear / Pixabay

Study Focuses on Muscle Weakness in Patients with Charcot-Marie-Tooth Disease Type 1A

According to a story from Charcot-Marie-Tooth News, a recent study has revealed that patients with Charcot-Marie-Tooth disease (CMT) type 1A still display signs of muscle weakness even if they retain…

Continue Reading Study Focuses on Muscle Weakness in Patients with Charcot-Marie-Tooth Disease Type 1A
Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness
harpenz / Pixabay

Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness

According to a story from Charcot-Marie-Tooth Disease News, Charcot-Marie-Tooth disease is actually somewhat common in the US compared to other rare diseases. In fact, it is estimated that around 150,000…

Continue Reading Estela Lugo of the Hereditary Neuropathy Foundation Seeks to Raise Charcot-Marie-Tooth Disease Awareness
First-of-its-Kind Study of Charcot-Marie-Tooth Disease Type 4J to Begin at UT Southwestern Med Center
Source: Pixabay

First-of-its-Kind Study of Charcot-Marie-Tooth Disease Type 4J to Begin at UT Southwestern Med Center

According to a publication from Charcot-Marie-Tooth News, the first patient has been enrolled in the first ever natural history study of type 4J Charcot-Marie-Tooth disease. Study collaborators — biotechnology company…

Continue Reading First-of-its-Kind Study of Charcot-Marie-Tooth Disease Type 4J to Begin at UT Southwestern Med Center
Study Identifies Differences in Progression and Onset Between Type 4B1 and 4B2 Charcot-Marie-Tooth Disease
Belova59 / Pixabay

Study Identifies Differences in Progression and Onset Between Type 4B1 and 4B2 Charcot-Marie-Tooth Disease

According to a story from Charcot-Marie-Tooth News, a recent study was conducted that compared the presentation of symptoms between two different variants of Charcot-Marie-Tooth disease (CMT): CMT4B1 and CMT4B2. The…

Continue Reading Study Identifies Differences in Progression and Onset Between Type 4B1 and 4B2 Charcot-Marie-Tooth Disease
Researchers Identify New Mutations Linked to Charcot-Marie-Tooth Disease
skeeze / Pixabay

Researchers Identify New Mutations Linked to Charcot-Marie-Tooth Disease

According to a story from Charcot-Marie-Tooth News, a team of scientists have successfully identified four new mutations that are capable of causing Charcot-Marie-Tooth disease. These mutations affect the GJB1 gene. These new…

Continue Reading Researchers Identify New Mutations Linked to Charcot-Marie-Tooth Disease